Advancements in SGLT2 Inhibitors: Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy With a Focus on Pharmacogenomics. Prospect. Pharm. Sci. 2025, 23 (1), 116-128. https://doi.org/10.56782/pps.274.